Why L.A. leads in Biotech and Life Sciences
A supportive ecosystem for revolutionary medical advancements.
The Future of Life Sciences
"
L.A.’s bio and life sciences ecosystem spans biotech, medtech, digital health, telemedicine, health IT, synthetic biology, and more. The facilities in Los Angeles County propel health service research and training, thanks to major medical schools and teaching hospitals that call the area home, such as the UCLA Medical Center, USC’s Keck School of Medicine, Cedars-Sinai Hospital, Cal Poly Pomona, City of Hope and more.
This progress-driven community has created space for organizations aimed at helping biotech companies thrive in Los Angeles. Connect with the Biolabs facility at the Lundquist Institute to earn guidance and general aid as a health science startup in the area. Or explore the Alliance for SoCal Innovation’s Wetlab list to explore research opportunities in the region.
3 Reasons Why
Why L.A. leads in
Sustainability &
Cleantech
1.
2.
3.
Los Angeles County received more NIH funding than any other county in California with $1.94 billion awarded in 2020.
​
​
20% of all California life science jobs are in Los Angeles County, nearly 10% of which are in the City of L.A.
​
​
In 2020, Los Angeles County’s life sciences industry generated $19 billion of labor income, according to BioCom.
By the numbers
$66.9B
Generated by L.A.’s bioscience sector in 2023, leading to uncharted growth for the sector.
#4
Among global cities for
most developed health
tech ecosystem.
223.9K
Jobs in the life sciences industry (direct/indirect
/induced) in 2024.
48%
Of employment in the
sector is in Research
and Manufacturing.
"California has always been a leader in life science innovation, and our 2024 Economic Impact Report shows the sustained value of the industry to the state’s economy. Accelerating the success of the life science industry requires a mission-driven mindset to nurture growth. The scientific breakthroughs that create lasting impact on human well-being involve significant financial risk, and the efforts are worth it. This is evidenced by the lasting economic impact of the industry’s work, as well as the advancements that generate dramatic improvements in patient health."
Joe Panetta, President and Chief Executive Officer, Biocom
Partner Organizations in Biotech and Life Sciences
